| Literature DB >> 35915543 |
Lei-Lei Cao1, Jun-Jie Chang1, Shao-Jie Wang1, Yong-Han Li1, Meng-Yuan Yuan1, Geng-Fu Wang1,2, Pu-Yu Su1,2.
Abstract
The incidence of infertility has recently risen. Semen quality is an important male fertility indicator, and dietary factors can affect semen quality. We conducted this systematic review and meta-analysis to determine the effects of healthy dietary patterns on semen quality. A literature search was conducted in 3 databases (Embase, Web of Science and PubMed) on August 21, 2021. The included cross-sectional studies examined the influence of the Mediterranean, Dietary Approaches to Stop Hypertension (DASH), and prudent diet patterns on semen quality parameters; six studies (1244 subjects) were included. By comparing high consumption with low consumption of healthy dietary patterns, the results of the meta-analysis showed significantly higher sperm concentrations (mean difference [MD] = 6.88 × 106 ml-1, 95% confidence interval [CI]: 1.26 × 106 ml-1-12.49 × 106 ml-1; P < 0.05), a significant increase in total sperm count (MD = 16.70 × 106, 95% CI: 2.37 × 106-31.03 × 106; P < 0.05), and a significant increase in progressive sperm motility (MD = 5.85%, 95% CI: 2.59%-9.12%; P < 0.01). The sperm concentration, progressive sperm motility, and total sperm count were significantly higher in men with higher versus lower consumption of healthy dietary patterns. However, the results must be interpreted with caution.Entities:
Keywords: cross-sectional study; healthy dietary pattern; meta-analysis; semen quality; systematic review
Mesh:
Year: 2022 PMID: 35915543 PMCID: PMC9491032 DOI: 10.4103/aja202252
Source DB: PubMed Journal: Asian J Androl ISSN: 1008-682X Impact factor: 3.054
Preferred reporting items for systematic reviews and meta-analyses guidelines
|
|
|
|
|
|---|---|---|---|
| Title | |||
| Title | 1 | Identify the report as a systematic review, meta-analysis, or both | 1 |
| Abstract | |||
| Structured summary | 2 | Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number | 2 |
| Introduction | |||
| Rationale | 3 | Describe the rationale for the review in the context of what is already known | 2–5 |
| Objectives | 4 | Provide an explicit statement of questions being addressed with reference to PICOS | 5 |
| Methods | |||
| Protocol and registration | 5 | Indicate if a review protocol exists, if and where it can be accessed ( | No |
| Eligibility criteria | 6 | Specify study characteristics ( | 6–7 |
| Information sources | 7 | Describe all information sources ( | 6 |
| Search | 8 | Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated | 6 |
| Study selection | 9 | State the process for selecting studies ( | 6–7 |
| Data collection process | 10 | Describe method of data extraction from reports ( | 7 |
| Data items | 11 | List and define all variables for which data were sought ( | No |
| Risk of bias in individual studies | 12 | Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis | 7–8 |
| Summary measures | 13 | State the principal summary measures ( | 8–9 |
| Synthesis of results | 14 | Describe the methods of handling data and combining results of studies, if done, including measures of consistency ( | 8–9 |
| Risk of bias across studies | 15 | Specify any assessment of risk of bias that may affect the cumulative evidence ( | 8–9 |
| Additional analyses | 16 | Describe methods of additional analyses ( | No |
| Results | |||
| Study selection | 17 | Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram | 9 |
| Study characteristics | 18 | For each study, present characteristics for which data were extracted ( | 10–11 |
| Risk of bias within studies | 19 | Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12) | 12 |
| Results of individual studies | 20 | For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot | 12–15 |
| Synthesis of results | 21 | Present results of each meta-analysis done, including confidence intervals and measures of consistency | 15–16 |
| Risk of bias across studies | 22 | Present results of any assessment of risk of bias across studies (see Item 15) | 15–16 |
| Additional analysis | 23 | Give results of additional analyses, if done ( | No |
| Discussion | |||
| Summary of evidence | 24 | Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups ( | 17–20 |
| Limitations | 25 | Discuss limitations at study and outcome level ( | 20–21 |
| Conclusions | 26 | Provide a general interpretation of the results in the context of other evidence, and implications for future research | 21 |
| Funding | |||
| Funding | 27 | Describe sources of funding for the systematic review and other support ( | 22 |
From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). PRISMA: The PRISMA Statement. PLoS Med 6 (6): e1000097. doi: 10.1371/journal.pmed1000097. PICOS: Participants, Interventions, Comparisons, Outcomes, and Study design; PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses
The characteristics of 6 studies
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Gaskins | 2012 | USA | 2009–2010 | Healthy | CS | 188 | 18–22 | 131-item FFQ | Prudent pattern, western pattern | Sperm concentration, progressive motility, and morphology |
| Cutillas-Tolín | 2015 | Spain | 2010–2011 | Healthy | CS | 209 | 18–23 | 101-item FFQ | MED, western diet | Semen volume, sperm concentration, total sperm count, morphologically normal sperm, and total motile sperm |
| Karayiannis | 2017 | Greece | 2013–2016 | Infertility | CS | 225 | 26–55 | 75-item FFQ | MED | Semen volume, sperm concentration, total sperm count, motility, progressive motility, and morphology |
| Salas-Huetos | 2019 | Spain | 2015–2017 | Healthy | CS | 106 | 18–35 | 143-item FFQ | MED | Semen volume, total sperm count, sperm concentration, vitality, total motility, progressive motility, and morphology |
| Ricci | 2019 | Italy | 2014–2016 | Infertility | CS | 390 | 27–60 | 78-item FFQ | MED | Semen volume, sperm concentration, and total count |
| Danielewicz | 2019 | Poland | 2014–2018 | Healthy | CS | 207 | 20–55 | 165-item FFQ | DASH | Semen volume, sperm concentration, sperm count, total motility, progressive motility, and morphology |
CS: cross-sectional study; FFQ: Food Frequency Questionnaire; MED: Mediterranean diet; DASH: Dietary Approaches to Stop Hypertension
Study population sources and semen analysis methods
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
| Gaskins | Healthy men from a cross-sectional study recruited at a university to study the effects of environmental pollutants on semen quality | Hemocytometer | Volume × sperm concentration | The slides were Papanicolaou stained and assessed using the Tygerberg strict criteria | The WHO criteria 4th edition | The WHO criteria 4th edition | Weighing |
| Cutillas-Tolín | Healthy men from a cross-sectional study aimed at studying the influence of environmental and lifestyle factors on semen quality and reproductive hormone levels | Hemocytometer | Volume × sperm concentration | The slides were prepared, air-dried, fixed, Papanicolaou stained, and assessed using the Tygerberg strict criteria | The WHO criteria 5th edition | NA | Weighing |
| Karayiannis | Infertile men from a cross-sectional study conducted at a fertility clinic in Athens, Greece | Hemocytometer | Volume × sperm concentration | The slides were Papanicolaou stained and assessed using the Tygerberg strict criteria | The WHO criteria 5th edition | The WHO criteria 5th edition | Weighing |
| Salas-Huetos | Healthy men from a parallel randomized clinical trial aimed to assess the effects of nut supplementation on sperm quality parameters | Hemocytometer | Volume × sperm concentration | The WHO criteria 5th edition | The WHO criteria 5th edition | The WHO criteria 5th edition | A Pasteur pipette |
| Ricci | Infertile men were invited to participate in an ongoing prospective cohort study on the role of lifestyle habits and diet on assisted reproduction technologies outcome from an Italian Fertility Clinic | Hemocytometer | Volume × sperm concentration | NA | NA | NA | Weighing |
| Danielewicz | Healthy men from a cross-sectional study who attended the left of reproductive medicine in Olsztyn (Poland) or voluntarily joined the study in 2014–2018 | A four-chamber GoldCyto slide (10 μm depth) by applying 4 μl of semen | CASA | The slides were Diff-Quick stained by using WHO criteria 5th edition | A four-chamber GoldCyto slide (10 μm depth) by applying 4 μl of semen | A four-chamber GoldCyto slide (10 μm depth) by applying 4 μl of semen | The WHO criteria 5th edition |
WHO: World Health Organization; NA: not available; CASA: computer-aided semen analysis
Quality rating of included studies using AHRQ
|
|
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Gaskins | √ | √ | √ | √ | √ | √ | √ | 7 | ||||
| Cutillas-Tolín | √ | √ | √ | √ | √ | √ | √ | √ | 8 | |||
| Karayiannis | √ | √ | √ | √ | √ | √ | √ | √ | 8 | |||
| Salas-Huetos | √ | √ | √ | √ | √ | √ | √ | 7 | ||||
| Ricci | √ | √ | √ | √ | √ | √ | √ | √ | 8 | |||
| Danielewicz | √ | √ | √ | √ | √ | √ | √ | √ | √ | 9 | ||
AHRQ: Agency for Health Care Research and Quality
Participants, Interventions, Comparisons, Outcomes, and Study design criteria for inclusion of studies
|
|
|
|---|---|
| Participants | Male with healthy dietary pattern |
| Intervention | Studies confirming diet assessed by dietary patterns, dietary scores, dietary indices, and food patterns |
| Comparison | Lower consumption of healthy dietary pattern |
| Outcomes | Six semen parameters |
| Study design | Cross-sectional studies |
PICOS: Participants, Interventions, Comparisons, Outcomes, and Study design
The data of the included studies in semen parameters
|
|
|
| ||||
|---|---|---|---|---|---|---|
|
|
| |||||
|
|
|
|
|
|
| |
| Sperm concentration (millions ml−1) | ||||||
| Gaskins | 47 | 51.20 | 68.63 | 47 | 44.30 | 58.92 |
| Cutillas-Tolín | 52 | 44.20 | 46.51 | 53 | 35.70 | 36.46 |
| Karayiannis | 66 | 37.90 | 26.43 | 76 | 30.50 | 27.14 |
| Salas-Huetos | 27 | 25.63 | 15.26 | 30 | 30.13 | 34.72 |
| Ricci | 35 | 37.67 | 36.15 | 31 | 34.30 | 44.56 |
| Danielewicz | 70 | 41.13 | 51.09 | 62 | 24.10 | 24.21 |
| Total sperm count (millions) | ||||||
| Cutillas-Tolín | 52 | 138.00 | 134.7 | 53 | 91.90 | 84.71 |
| Karayiannis | 66 | 82.10 | 70.75 | 76 | 63.80 | 72.67 |
| Salas-Huetos | 27 | 74.50 | 45.00 | 30 | 82.30 | 84.61 |
| Ricci | 35 | 85.77 | 75.62 | 31 | 81.43 | 107.29 |
| Danielewicz | 70 | 154.27 | 188.78 | 62 | 90.53 | 102.02 |
| Normal sperm morphology (%) | ||||||
| Gaskins | 47 | 7.80 | 6.30 | 47 | 8.70 | 6.30 |
| Cutillas-Tolín | 52 | 8.17 | 5.57 | 53 | 9.25 | 6.15 |
| Karayiannis | 66 | 4.60 | 2.44 | 76 | 4.30 | 2.63 |
| Salas-Huetos | 27 | 6.43 | 2.35 | 30 | 6.27 | 2.80 |
| Danielewicz | 70 | 8.33 | 6.81 | 62 | 6.33 | 3.79 |
| Total sperm motility (%) | ||||||
| Cutillas-Tolín | 52 | 56.10 | 11.31 | 53 | 56.20 | 10.70 |
| Karayiannis | 66 | 42.60 | 20.33 | 76 | 32.10 | 20.57 |
| Salas-Huetos | 27 | 73.37 | 13.70 | 30 | 55.23 | 26.15 |
| Danielewicz | 70 | 53.90 | 20.59 | 62 | 50.90 | 17.30 |
| Progressive sperm motility (%) | ||||||
| Gaskins | 47 | 63.70 | 20.26 | 47 | 57.10 | 19.58 |
| Karayiannis | 66 | 26.00 | 16.26 | 76 | 20.00 | 16.63 |
| Salas-Huetos | 27 | 52.60 | 14.87 | 30 | 40.17 | 20.50 |
| Danielewicz | 70 | 33.80 | 17.49 | 62 | 30.80 | 14.88 |
| Semen volume (ml) | ||||||
| Cutillas-Tolín | 52 | 2.97 | 1.99 | 53 | 2.50 | 1.61 |
| Karayiannis | 66 | 2.10 | 0.81 | 76 | 2.00 | 1.31 |
| Salas-Huetos | 27 | 3.27 | 1.80 | 30 | 3.07 | 2.02 |
| Ricci | 35 | 2.73 | 1.88 | 31 | 2.77 | 1.58 |
| Danielewicz | 70 | 3.77 | 1.89 | 62 | 4.17 | 1.59 |
s.d.: standard deviation